Literature DB >> 30124942

(Micro)Glia as Effectors of Cortical Volume Loss in Schizophrenia.

Allyson P Mallya1, Ariel Y Deutch1,2,3.   

Abstract

Contrary to the notion that neurology but not psychiatry is the domain of disorders evincing structural brain alterations, it is now clear that there are subtle but consistent neuropathological changes in schizophrenia. These range from increases in ventricular size to dystrophic changes in dendritic spines. A decrease in dendritic spine density in the prefrontal cortex (PFC) is among the most replicated of postmortem structural findings in schizophrenia. Examination of the mechanisms that account for the loss of dendritic spines has in large part focused on genes and molecules that regulate neuronal structure. But the simple question of what is the effector of spine loss, ie, where do the lost spines go, is unanswered. Recent data on glial cells suggest that microglia (MG), and perhaps astrocytes, play an important physiological role in synaptic remodeling of neurons during development. Synapses are added to the dendrites of pyramidal cells during the maturation of these neurons; excess synapses are subsequently phagocytosed by MG. In the PFC, this occurs during adolescence, when certain symptoms of schizophrenia emerge. This brief review discusses recent advances in our understanding of MG function and how these non-neuronal cells lead to structural changes in neurons in schizophrenia.

Entities:  

Mesh:

Year:  2018        PMID: 30124942      PMCID: PMC6101531          DOI: 10.1093/schbul/sby088

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  184 in total

Review 1.  Translocator protein (18 kDa): an update on its function in steroidogenesis.

Authors:  V Papadopoulos; J Fan; B Zirkin
Journal:  J Neuroendocrinol       Date:  2018-02       Impact factor: 3.627

Review 2.  Complementary distribution of vesicular glutamate transporters in the central nervous system.

Authors:  Takeshi Kaneko; Fumino Fujiyama
Journal:  Neurosci Res       Date:  2002-04       Impact factor: 3.304

3.  18F-PBR111 PET Imaging in Healthy Controls and Schizophrenia: Test-Retest Reproducibility and Quantification of Neuroinflammation.

Authors:  Julie Ottoy; Livia De Picker; Jeroen Verhaeghe; Steven Deleye; Leonie Wyffels; Lauren Kosten; Bernard Sabbe; Violette Coppens; Maarten Timmers; Luc van Nueten; Sarah Ceyssens; Sigrid Stroobants; Manuel Morrens; Steven Staelens
Journal:  J Nucl Med       Date:  2018-01-11       Impact factor: 10.057

4.  A quantitative immunohistochemical study of astrocytes in the entorhinal cortex in schizophrenia, bipolar disorder and major depression: absence of significant astrocytosis.

Authors:  R Damadzic; L B Bigelow; L S Krimer; D A Goldenson; R C Saunders; J E Kleinman; M M Herman
Journal:  Brain Res Bull       Date:  2001-07-15       Impact factor: 4.077

5.  Neuroanatomical maps of psychosis onset: voxel-wise meta-analysis of antipsychotic-naive VBM studies.

Authors:  Paolo Fusar-Poli; Joaquim Radua; Philip McGuire; Stefan Borgwardt
Journal:  Schizophr Bull       Date:  2011-11-10       Impact factor: 9.306

6.  Inhibition of protein kinase C signaling protects prefrontal cortex dendritic spines and cognition from the effects of chronic stress.

Authors:  Avis Brennan Hains; Mai Anh T Vu; Paul K Maciejewski; Christopher H van Dyck; Melissa Gottron; Amy F T Arnsten
Journal:  Proc Natl Acad Sci U S A       Date:  2009-09-11       Impact factor: 11.205

Review 7.  Visualising microglial activation in vivo.

Authors:  Richard B Banati
Journal:  Glia       Date:  2002-11       Impact factor: 8.073

8.  Pro-inflammatory activation of primary microglia and macrophages increases 18 kDa translocator protein expression in rodents but not humans.

Authors:  David R Owen; Nehal Narayan; Lisa Wells; Luke Healy; Erica Smyth; Eugenii A Rabiner; Dylan Galloway; John B Williams; Joshua Lehr; Harpreet Mandhair; Laura An Peferoen; Peter C Taylor; Sandra Amor; Jack P Antel; Paul M Matthews; Craig S Moore
Journal:  J Cereb Blood Flow Metab       Date:  2017-05-22       Impact factor: 6.200

9.  Brain TSPO imaging and gray matter volume in schizophrenia patients and in people at ultra high risk of psychosis: An [11C]PBR28 study.

Authors:  Sudhakar Selvaraj; Peter S Bloomfield; Bo Cao; Mattia Veronese; Federico Turkheimer; Oliver D Howes
Journal:  Schizophr Res       Date:  2017-10-12       Impact factor: 4.939

Review 10.  Microglia and Brain Plasticity in Acute Psychosis and Schizophrenia Illness Course: A Meta-Review.

Authors:  Livia J De Picker; Manuel Morrens; Steven A Chance; Delphine Boche
Journal:  Front Psychiatry       Date:  2017-11-16       Impact factor: 4.157

View more
  4 in total

Review 1.  Roles of inflammation in intrinsic pathophysiology and antipsychotic drug-induced metabolic disturbances of schizophrenia.

Authors:  Tyler R Prestwood; Roshanak Asgariroozbehani; Sally Wu; Sri Mahavir Agarwal; Ryan W Logan; Jacob S Ballon; Margaret K Hahn; Zachary Freyberg
Journal:  Behav Brain Res       Date:  2021-01-14       Impact factor: 3.332

2.  Synapse Pathology in Schizophrenia: A Meta-analysis of Postsynaptic Elements in Postmortem Brain Studies.

Authors:  Amber Berdenis van Berlekom; Cita H Muflihah; Gijsje J L J Snijders; Harold D MacGillavry; Jinte Middeldorp; Elly M Hol; René S Kahn; Lot D de Witte
Journal:  Schizophr Bull       Date:  2020-02-26       Impact factor: 9.306

Review 3.  Neuroplastin in Neuropsychiatric Diseases.

Authors:  Xiao Lin; Yi Liang; Rodrigo Herrera-Molina; Dirk Montag
Journal:  Genes (Basel)       Date:  2021-09-26       Impact factor: 4.096

Review 4.  The role of microglia in neuropsychiatric disorders and suicide.

Authors:  Ralf Brisch; Szymon Wojtylak; Arthur Saniotis; Johann Steiner; Tomasz Gos; Jaliya Kumaratilake; Maciej Henneberg; Rainer Wolf
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2021-09-30       Impact factor: 5.760

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.